Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idacorp (IDA) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Idacorp (IDA) over the last 17 years, with Q3 2025 value amounting to $333.2 million.

  • Idacorp's Cash & Equivalents fell 2213.83% to $333.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $333.2 million, marking a year-over-year decrease of 2213.83%. This contributed to the annual value of $368.9 million for FY2024, which is 1265.5% up from last year.
  • Idacorp's Cash & Equivalents amounted to $333.2 million in Q3 2025, which was down 2213.83% from $474.5 million recorded in Q2 2025.
  • Over the past 5 years, Idacorp's Cash & Equivalents peaked at $634.5 million during Q1 2025, and registered a low of $134.8 million during Q2 2023.
  • In the last 5 years, Idacorp's Cash & Equivalents had a median value of $260.0 million in 2021 and averaged $300.4 million.
  • Per our database at Business Quant, Idacorp's Cash & Equivalents plummeted by 5596.06% in 2024 and then surged by 30264.18% in 2025.
  • Idacorp's Cash & Equivalents (Quarter) stood at $215.2 million in 2021, then fell by 17.5% to $177.6 million in 2022, then skyrocketed by 84.39% to $327.4 million in 2023, then increased by 12.65% to $368.9 million in 2024, then dropped by 9.67% to $333.2 million in 2025.
  • Its Cash & Equivalents was $333.2 million in Q3 2025, compared to $474.5 million in Q2 2025 and $634.5 million in Q1 2025.